Memorial Sloan Kettering Cancer Center MSK Pulmo-Oncology Symposium 2024
$50,00
This Product is shared via google drive download link, So please share your correct Gmail id while placing the order .Please note that there are no CME points or certificate associated with this course Samples for Courses Can be found here : Free Samples Here!
Include: 15 videos + 14 pdfs, size: 3.13 GB
Memorial Sloan Kettering Cancer Center MSK Pulmo-Oncology Symposium 2024
Include: 15 videos + 14 pdfs, size: 3.13 GB
Target Audience: pulmonologists, hematologists and oncologists
Information:
Friday, September 20, 2024, 7:55 AM – 5:00 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY
Pulmo-Oncology is an emerging discipline that has great importance to the clinical care of cancer patients. The respiratory system is often impacted by direct cancer involvement as well as by infections and toxicities stemming from the use of anti-neoplastic agents. Pre-existing pulmonary disorders affect patient outcomes and management decisions. Effective clinical management of pulmonary complications of cancer and its therapies requires an interdisciplinary approach.
In this multidisciplinary symposium, clinical experts from Memorial Sloan Kettering (MSK) and around the world, will present an up-to-date overview on cutting edge cancer therapies and best practice strategies in the evaluation and management of lung disease. The purpose of this conference is to provide a state-of-the-art, case-based, multidisciplinary curriculum that addresses selected topics relevant to the respiratory health of patients with cancer.
The symposium offers participants the choice of attending either in person or virtually and is intended for healthcare professionals in pulmonology, hematology and oncology, and other disciplines involved in the care of cancer patients or who have a special interest in this area.
Memorial Sloan Kettering Cancer Center MSK Pulmo-Oncology Symposium 2024
- Explain the role of the pulmonologist in diagnosis and management of lung cancer
- Identify state of the art treatment strategies for management of lung cancer and check point inhibitor pneumonitis
- Implement strategies for diagnosis and management of infectious and non-infectious pulmonary complications of stem cell transplant
- Discuss multidisciplinary approach in complex patients.
- Explain the diagnosis and clinical significance of pre-existing interstitial lung abnormalities and interstitial lung disease in cancer management
Topics:
- Case Presentation II.mp4
- Case Presentation.mp4
- Hypersensitivity Reactions to Cancer Treatments.mp4
- Hypersensitivity Reactions to Cancer Treatments.pdf
- ICI Pneumonitis- Second Line Treatment and Future Directions.mp4
- ICI Pneumonitis- Second Line Treatment and Future Directions.pdf
- Infections in the Immunocompromised Host.mp4
- Infections in the Immunocompromised Host.pdf
- IPF, Lung Cancer Surgery and Radiation- A Pulmonologist’s Perspective.mp4
- IPF, Lung Cancer Surgery and Radiation- A Pulmonologist’s Perspective.pdf
- New Drugs and Combos in Lung Cancer Land.mp4
- New Drugs and Combos in Lung Cancer Land.pdf
- Pulmonary Graft vs Host Disease (GVHD)- Management, Limitations and Future Directions.mp4
- Pulmonary Graft vs Host Disease (GVHD)- Management, Limitations and Future Directions.pdf
- Pulmonary Toxicity of Cancer Therapy.mp4
- Pulmonary Toxicity of Cancer Therapy.pdf
- PulmoOnc2024-Brochure.pdf
- Role of Cryobiopsy in Diagnosis of Inflammatory Disease.mp4
- Role of Cryobiopsy in Diagnosis of Inflammatory Disease.pdf
- Role of Pulmonologist in Diagnosis and Management of Lung Cancer.mp4
- Role of Pulmonologist in Diagnosis and Management of Lung Cancer.pdf
- Strategies for the Mitigation of Radiation Pneumonitis and the Role of Multidisciplinary Collaboration- A Radiation Oncology’s Perspective.mp4
- Strategies for the Mitigation of Radiation Pneumonitis and the Role of Multidisciplinary Collaboration- A Radiation Oncology’s Perspective.pdf
- The Paradox of TB Reactivation on Immune Checkpoint Inhibitor Therapy. Too Much of a Good Thing.mp4
- The Paradox of TB Reactivation on Immune Checkpoint Inhibitor Therapy. Too Much of a Good Thing.pdf
- Updates on Surgical Management in Lung Cancer.mp4
- Updates on Surgical Management in Lung Cancer.pdf
- When Oncology Meets ILD- Background and Clinical Implication.mp4
- When Oncology Meets ILD- Background and Clinical Implication.pdf
Related products
HARVARD MEDICINE
HARVARD MEDICINE
Harvard Internal Medicine Comprehensive Review and Update 2023
ENDOCRINE / NUTRITION
Harvard Updates in General Internal Medicine for Specialists 2022
INTERNAL MEDICINE
Oakstone Intensive Update with Board Review in Geriatric and Palliative Medicine 2022
ENDOCRINE / NUTRITION
Intensive Update with Board Review in Geriatric & Palliative Medicine 2023
CRITICAL CARE / EMERGENCY MEDICINE